Robert S Dufresne

Title: The Innovations of Robert S. Dufresne

Introduction

Robert S. Dufresne is a notable inventor based in Wellesley, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antiviral peptides. His work focuses on enhancing the stability and efficacy of these peptides, which are crucial in combating viral infections.

Latest Patents

Dufresne holds a patent for "Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group." This innovative patent describes peptides that exhibit anti-viral and anti-fusogenic activity, modified to provide greater stability and improved half-life in vivo. The selected peptides include fusion inhibitors DP178 and DP107, along with related peptides and analogs. These modified peptides are capable of forming covalent bonds with one or more blood components, preferably a mobile blood component.

Career Highlights

Throughout his career, Dufresne has been associated with Conjuchem Biotechnologies Inc., where he has contributed to groundbreaking research in the field of biopharmaceuticals. His work has been instrumental in advancing the understanding of peptide modifications and their applications in medicine.

Collaborations

Dufresne has collaborated with several esteemed colleagues, including Dominique P. Bridon and Nisssab Boudjellab. These collaborations have fostered a productive environment for innovation and research in the biotechnology sector.

Conclusion

Robert S. Dufresne's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of antiviral therapies, showcasing the importance of research and innovation in addressing global health challenges.